Conditional probability: A new fusion method for merging disparate virtual screening results

被引:21
作者
Raymond, JW [1 ]
Jalaie, M [1 ]
Bradley, MP [1 ]
机构
[1] Pfizer Global Res & Dev, Discovery Technol, Ann Arbor Labs, Ann Arbor, MI 48105 USA
来源
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES | 2004年 / 44卷 / 02期
关键词
D O I
10.1021/ci034234o
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper introduces a new consensus scoring approach for merging the results of different virtual screening methods based on conditional probabilities. The technique is experimentally evaluated using several ligand-based virtual screening methods and compared to two variations of the established Sum-rank fusion method where it performs as well or better than the Sum-rank methods. Our experiments confirm that consensus scoring increases the number of active compounds retrieved with respect to the best individual methods on average.
引用
收藏
页码:601 / 609
页数:9
相关论文
共 38 条
[1]   Synthesis and structure-activity relationship of α-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis [J].
Aranapakam, V ;
Grosu, GT ;
Davis, JM ;
Hu, BH ;
Ellingboe, J ;
Baker, JL ;
Skotnicki, JS ;
Zask, A ;
DiJoseph, JF ;
Sung, A ;
Sharr, MA ;
Killar, LM ;
Walter, T ;
Jin, GX ;
Cowling, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) :2361-2375
[2]   Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis [J].
Aranapakam, V ;
Davis, JM ;
Grosu, GT ;
Baker, J ;
Ellingboe, J ;
Zask, A ;
Levin, JI ;
Sandanayaka, VP ;
Du, ML ;
Skotnicki, JS ;
DiJoseph, JF ;
Sung, A ;
Sharr, MA ;
Killar, LM ;
Walter, T ;
Jin, GX ;
Cowling, R ;
Tillett, J ;
Zhao, WU ;
McDevitt, J ;
Xu, ZB .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) :2376-2396
[3]  
Bajorath J., 2002, Curr. Drug Discov., V3, P24
[4]   Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A2A and A3 adenosine receptors antagonists [J].
Baraldi, PG ;
Fruttarolo, F ;
Tabrizi, MA ;
Preti, D ;
Romagnoli, R ;
El-Kashef, H ;
Moorman, A ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1229-1241
[5]   Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres:: A new class of potent and selective acetylcholinesterase inhibitors [J].
Barreiro, EJ ;
Camara, CA ;
Verli, H ;
Brazil-Más, L ;
Castro, NG ;
Cintra, WM ;
Aracava, Y ;
Rodrigues, CR ;
Fraga, CAM .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1144-1152
[6]  
Belkin Nicholas J., 1993, P 16 ANN INT ACM SIG, P339
[7]   N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor [J].
Beukers, MW ;
Wanner, MJ ;
Künzel, JKV ;
Klaasse, EC ;
IJzerman, AP ;
Koomen, GJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) :1492-1503
[8]   Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists [J].
Böhme, TM ;
Keim, C ;
Kreutzmann, K ;
Linder, M ;
Dingermann, T ;
Dannhardt, G ;
Mutschler, E ;
Lambrecht, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (05) :856-867
[9]   Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligand [J].
Choi-Sledeski, YM ;
Kearney, R ;
Poli, G ;
Pauls, H ;
Gardner, C ;
Gong, Y ;
Becker, M ;
Davis, R ;
Spada, A ;
Liang, G ;
Chu, V ;
Brown, K ;
Collussi, D ;
Leadley, R ;
Rebello, S ;
Moxey, P ;
Morgan, S ;
Bentley, R ;
Kasiewski, C ;
Maignan, S ;
Guilloteau, JP ;
Mikol, V .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (05) :681-684
[10]   dbtop:: Toporner similarity searching of conventional structure databases [J].
Cramer, RD ;
Jilek, RJ ;
Andrews, KM .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (06) :447-462